Global Markets Directs, Breast Cancer Pipeline Review, H1 2015, provides an overview of the Breast Cancers therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Breast Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Breast Cancer and special features on late-stage and discontinued projects. Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Scope The report provides a snapshot of the global therapeutic landscape of Breast Cancer The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved in the therapeutics development for Breast Cancer and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline projects A review of the Breast Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Breast Cancer pipeline on the basis of target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products Reasons to buy Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies

1. Breast Cancer - Pipeline Review, H1 2015
Global Markets Directs, Breast Cancer Pipeline Review, H1 2015, provides an overview of the Breast Cancers therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Breast Cancer, complete with comparative analysis at various stages,
therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured
news and press releases. It also reviews key players involved in the therapeutic development for Breast Cancer and special features on late-stage and discontinued
projects.
Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built
using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the
latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that
the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by
identifying new targets and MOAs to produce first-in-class and best-in-class products.
Scope
The report provides a snapshot of the global therapeutic landscape of Breast Cancer The report reviews key pipeline products under drug profile section which
includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities The report reviews key players involved
in the therapeutics development for Breast Cancer and enlists all their major and minor projects The report summarizes all the dormant and discontinued pipeline
projects A review of the Breast Cancer products under development by companies and universities/research institutes based on information derived from
company and industry-specific sources Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and
undisclosed stages A detailed assessment of monotherapy and combination therapy pipeline projects Coverage of the Breast Cancer pipeline on the basis of
target, MoA, route of administration and molecule type Latest news and deals relating related to pipeline products
Reasons to buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies Identify emerging players
with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage Develop strategic initiatives by understanding the
focus areas of leading companies Identify and understand important and diverse types of therapeutics under development for Breast Cancer Plan mergers and
acquisitions effectively by identifying key players of the most promising pipeline Devise corrective measures for pipeline projects by understanding Breast
Cancer pipeline depth and focus of Indication therapeutics Develop and design in-licensing and out-licensing strategies by identifying prospective partners with
the most attractive projects to enhance and expand business potential and scope Modify the therapeutic portfolio by identifying discontinued projects and
understanding the factors that drove them from pipeline
table Of Contents 2
introduction 16
breast Cancer Overview 17
therapeutics Development 18
breast Cancer - Therapeutics Under Development By Companies 20
breast Cancer - Therapeutics Under Investigation By Universities/institutes 51
breast Cancer - Pipeline Products Glance 60
breast Cancer - Products Under Development By Companies 64
breast Cancer - Products Under Investigation By Universities/institutes 111
breast Cancer - Companies Involved In Therapeutics Development 122
breast Cancer - Therapeutics Assessment 468
drug Profiles 510
breast Cancer - Recent Pipeline Updates 1716
breast Cancer - Dormant Projects 2169
breast Cancer - Discontinued Products 2208
breast Cancer - Product Development Milestones 2219
appendix 2231
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
Sales Team,
90 State Street,
Suite 700,
Breast Cancer - Pipeline Review, H1 2015

2. Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Breast Cancer - Pipeline Review, H1 2015